Live Markets
Tuesday, July 28, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

GeneDx Holdings Corp. (WGS)

NMS · Diagnostics & Research

$61.88+1.34 (+2.21%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$1.84B
P/E (TTM)
EPS
$-2.72
Div Yield
52W Range
$32.21–$170.87
Beta
1.91

Company overview

Next earnings: 2026-08-03(6d)

GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.

Peers in Diagnostics & Research

All in industry →

Recent press releases

GeneDx Holdings Corp. has not issued a press release in this window.

SEC filings

All filings →

GeneDx Holdings Corp. has not filed an SEC document in this window.

GeneDx Holdings Corp. has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for GeneDx Holdings Corp. in this window.

People at GeneDx Holdings Corp.

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for GeneDx Holdings Corp..

WGS (NMS) Stock Quote, Press Releases & SEC... | Cayman Journal | Cayman Journal